Potential therapeutic role of GLP-1 receptor agonists in Idiopathic intracranial hypertension: a systematic review and meta-analysis.

However, no significant improvements were observed in objective visual parameters, including visual acuity, visual field, or peripapillary retinal nerve fiber layer (pRNFL) thickness.

GLP-1RA therapy was associated with reduced headache incidence (RR = 0.74, 95% CI: 0.54-1.00) and fewer monthly headache days (SMD = -0.77, 95% CI: -1.35 to -0.19).

Changes in BMI were not significant (SMD = -0.06, 95% CI: -0.15 to 0.02).